Literature DB >> 17666476

Deterioration of growth hormone (GH) response and anterior pituitary function in young adults with childhood-onset GH deficiency and ectopic posterior pituitary: a two-year prospective follow-up study.

Natascia di Iorgi1, Andrea Secco, Flavia Napoli, Carmine Tinelli, Annalisa Calcagno, Nadia Fratangeli, Linda Ambrosini, Andrea Rossi, Renata Lorini, Mohamad Maghnie.   

Abstract

CONTEXT: The current criteria for definition of partial GHD in young adults are still a subject of debate.
OBJECTIVES: The objective of the study was to reinvestigate anterior pituitary function in young adults with congenital childhood-onset GHD associated with structural hypothalamic-pituitary abnormalities and normal GH response at the time of first reassessment of GH secretion. DESIGN AND
SETTING: This was a prospective explorative study conducted in a university research hospital. PATIENTS AND METHODS: Thirteen subjects with a mean age of 17.2 +/- 0.7 yr and a peak GH after insulin tolerance test (ITT) higher than 5 microg/liter were recruited from a cohort of 42 patients with childhood-onset GHD and ectopic posterior pituitary at magnetic resonance imaging. GH secretion after ITT and GHRH plus arginine, IGF-I concentration, and body mass index, waist circumference, blood pressure, total cholesterol, and fibrinogen were evaluated at baseline and at 2-yr follow-up.
RESULTS: At mean age of 19.2 +/- 0.7 yr, the mean peak GH response decreased significantly after ITT (P = 0.00001) and GHRH plus arginine (P = 0.0001). GH peak values after ITT and GHRH plus arginine were less than 5 and 9 microg/liter in 10 and eight patients, respectively. Additional pituitary defects were documented in eight patients. Significant changes were found in the values of IGF-I sd score (P = 0.0026), waist circumference (P = 0.00001), serum total cholesterol (P = 0.00001), and serum fibrinogen (P = 0.0004).
CONCLUSIONS: The results of this study underline the importance of further reassessment of pituitary function in young adults with GHD of childhood-onset and poststimulation GH responses suggestive of partial GHD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666476     DOI: 10.1210/jc.2007-1081

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Frequent development of combined pituitary hormone deficiency in patients initially diagnosed as isolated growth hormone deficiency: a long term follow-up of patients from a single center.

Authors:  Aline P Otto; Marcela M França; Fernanda A Correa; Everlayny F Costalonga; Claudia C Leite; Berenice B Mendonca; Ivo J P Arnhold; Luciani R S Carvalho; Alexander A L Jorge
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

2.  Correlation between adrenal function, growth hormone secretion, and insulin sensitivity in children with idiopathic growth hormone deficiency.

Authors:  A Ciresi; S Radellini; E Vigneri; V Guarnotta; J Bianco; M G Mineo; C Giordano
Journal:  J Endocrinol Invest       Date:  2017-08-18       Impact factor: 4.256

Review 3.  Genetic causes and treatment of isolated growth hormone deficiency-an update.

Authors:  Kyriaki S Alatzoglou; Mehul T Dattani
Journal:  Nat Rev Endocrinol       Date:  2010-10       Impact factor: 43.330

4.  Appropriate management of growth hormone deficiency during the age of transition: an Italian Delphi consensus statement.

Authors:  S Cannavò; M Cappa; D Ferone; A M Isidori; S Loche; M Salerno; M Maghnie
Journal:  J Endocrinol Invest       Date:  2022-08-12       Impact factor: 5.467

5.  Diagnostic pitfalls in the assessment of congenital hypopituitarism.

Authors:  Paolo Cavarzere; Paolo Biban; Rossella Gaudino; Silvia Perlini; Lorenzo Sartore; Lorenza Chini; Davide Silvagni; Franco Antoniazzi
Journal:  J Endocrinol Invest       Date:  2014-08-01       Impact factor: 4.256

6.  United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthood.

Authors:  Charmian A Quigley; Anthony J Zagar; Charlie Chunhua Liu; David M Brown; Carol Huseman; Lynne Levitsky; David R Repaske; Eva Tsalikian; John J Chipman
Journal:  Int J Pediatr Endocrinol       Date:  2013-02-13

7.  Approach to the Patient: Management of Pituitary Hormone Replacement Through Transition.

Authors:  Manuela Cerbone; Harshini Katugampola; Helen L Simpson; Mehul T Dattani
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

8.  Accuracy and Limitations of the Growth Hormone (GH) Releasing Hormone-Arginine Retesting in Young Adults With Childhood-Onset GH Deficiency.

Authors:  Giuseppa Patti; Serena Noli; Donatella Capalbo; Anna Maria Elsa Allegri; Flavia Napoli; Marco Cappa; Grazia Maria Ubertini; Annalisa Gallizia; Sara Notarnicola; Anastasia Ibba; Marco Crocco; Stefano Parodi; Mariacarolina Salerno; Sandro Loche; Maria Luisa Garré; Elena Tornari; Mohamad Maghnie; Natascia Di Iorgi
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-31       Impact factor: 5.555

Review 9.  Important Tools for Use by Pediatric Endocrinologists in the Assessment of Short Stature

Authors:  José I. Labarta; Michael B. Ranke; Mohamad Maghnie; David Martin; Laura Guazzarotti; Roland Pfäffle; Ekaterina Koledova; Jan M. Wit
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-10-02

10.  The Challenge of Growth Hormone Deficiency Diagnosis and Treatment during the Transition from Puberty into Adulthood.

Authors:  Elena Inzaghi; Stefano Cianfarani
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-20       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.